Literature DB >> 18982837

Antipsychotic treatment in schizophrenia: the role of computerized neuropsychological assessment.

Semion Kertzman1, Ilya Reznik, Haim Grinspan, Abraham Weizman, Moshe Kotler.   

Abstract

The present study analyzes the role of neurocognitive assessment instruments in the detection of the contribution of antipsychotic treatment to cognitive functioning. Recently, a panel of experts suggested six main domains (working memory; attention/vigilance; verbal/visual learning and memory; reasoning and problem solving; speed of processing) implicated in schizophrenia-related cognitive deficits, which serve as a theoretical base for creation of real-time computerized neurocognitive batteries. The high sensitivity of computerized neuropsychological testing is based on their ability to adopt the reaction time (RT) paradigm for the assessment of brain function in a real-time regime. This testing is highly relevant for the monitoring of the cognitive effects of antipsychotics. Computerized assessment assists in the identification of state- and trait-related cognitive impairments. The optimal real-time computerized neurocognitive battery should composite balance between broad and narrow coverage of cognitive domains relevant to the beneficial effects of antipsychotics and will enable better planning of treatment and rehabilitation programs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18982837

Source DB:  PubMed          Journal:  Isr J Psychiatry Relat Sci        ISSN: 0333-7308            Impact factor:   0.481


  2 in total

1.  Genetic Effects of DISC1 and G72 (DAOA) on Visual Learning of Patients with Schizophrenia.

Authors:  Jane Pei-Chen Chang; Kuo-Hao Huang; Hsien-Yuan Lane; Chieh-Hsin Lin
Journal:  Neuropsychiatr Dis Treat       Date:  2020-03-20       Impact factor: 2.570

Review 2.  P300, a tool for cognitive assessment in women with iron deficiency anemia: A systematic review.

Authors:  Umme Kulsoom Sheema; Alka Rawekar
Journal:  J Family Med Prim Care       Date:  2022-06-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.